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Abstract
Objectives—We examined the use of voluntary HIV testing among state prisoners in the North
Carolina prison system.
Methods—We calculated system-wide and facility-specific proportions and rates of adult inmates
tested for HIV and estimated associations between testing status and inmate characteristics for
prisoners in North Carolina.
Results—Of the 54016 inmates who entered prison between January 2004 and May 2006, 20820
(38%) were tested for HIV; of those tested, 18574 (89%) were tested at admission. Across the 8
intake prisons, more than 80% of inmates in both female facilities but less than 15% of inmates in 4
of 6 male facilities were tested. Prisoners with a documented history of heroin use, crack or cocaine
use, conventional HIV risk behavior, or tuberculosis were at least 10% more likely to be tested than
were inmates without these characteristics. However, more than 60% of men reporting conventional
risk behaviors were not tested. Before covariate adjustment, Black men were 30% less likely than
White men to be tested; in the multivariable regression model, this difference was attenuated to 13%.
Conclusions—Rates of HIV testing varied widely across intake prisons, and many male inmates
with documented risk of infection were never tested.
The prevalence of HIV is disproportionately high among incarcerated individuals compared
with the general US population.1 Although some evidence suggests that HIV is transmitted
within prisons, most infections occur in the community.2,3 Given inmates’ limited access to
community health care,4 prisons provide an important opportunity to conduct HIV testing.
Among the benefits of testing are that infected inmates can initiate medical care and, if
appropriate, initiate highly active antiretroviral therapy (HAART). HAART is now widely
available in prison systems, and prisoners have experienced declines in HIV-related mortality
similar to those in the community.5,6 A positive HIV test may also initiate contact tracing to
identify infection among inmates’ sexual or drug-using partners in the community and in
prison.
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HIV testing strategies vary across US state prison systems. According to Bureau of Justice
statistics, 20 state prison systems have instituted mandatory HIV testing. The other 29 prison
systems provide consent-based testing (data from Alaska were unavailable).7 Nearly all
systems provide testing upon prisoners’ self-request. Among systems with consent-based
testing, at least 2 provide opt-out testing (i.e., inmates are informed that they will be tested
unless they actively decline)8 and 12 target testing to “high-risk” prisoners. Yet, little is known
about the extent of HIV testing in prisons with consent-based testing or the degree to which
testing in these systems includes prisoners with known risk factors. In addition, most existing
US studies that examined the use of voluntary HIV testing were conducted before the era of
HAART, and few have characterized the differences between testers and nontesters.9-14
In 2003, as part of its Advancing HIV Prevention initiative, the Centers for Disease Control
and Prevention (CDC) recommended that correctional facilities offer HIV testing at the time
of intake.15 With the CDC’s 2006 recommendations to improve access to HIV testing with the
implementation of routine opt-out testing across health care settings, including correctional
health care facilities,16 it is of renewed interest to examine the extent of HIV testing in prisons
with consent-based testing. Low rates of testing may indicate missed opportunities to provide
needed medical care and social support, reduce infectiousness via treatment, and provide
counseling to reduce secondary transmission.
In our study, we examined the use of consent-based HIV testing in a large southern prison
system, the North Carolina Department of Correction (NC DOC) Division of Prisons. We
determined the proportion of inmates tested for HIV both during and after admission, examined
differences in testing across intake prisons, and estimated associations between receipt of an
HIV test and prisoner characteristics to detect disparities in testing, particularly among inmates
with documented risk for infection.
METHODS
Before assignment to 1 of the 76 prisons in the NC DOC prison system, incoming inmates are
admitted to 1 of 8 intake prisons that has a processing and diagnostic center. Two centers are
designated for adult women, 4 for adult men, and 2 for younger men (i.e., younger than 22
years). Inmates receive a presentation about blood-borne diseases, including HIV. A medical
evaluation is conducted including routine testing for syphilis and tuberculosis (TB). A nurse
screens inmates for conventional HIV risk behaviors, and voluntary HIV testing is available;
during the study period, it was NC DOC policy to offer inmates with known risk behaviors an
HIV test. HIV testing is available anytime during incarceration by inmate self-request, by
clinician recommendation, or after a blood exposure incident. Inmates testing positive are seen
regularly by a physician who specializes in HIV treatment, and antiretroviral therapy is initiated
per community recommendations. HIV testing is conducted with conventional enzyme-linked
immunosorbent assay (ELISA) and Western blot tests. Inmates typically receive test results
within 1 week. HCV antibody testing is provided to prisoners with clinical symptoms of
hepatitis and to all prisoners with known HIV infection.
Assessments of inmates’ social (e.g., employment and marital status) and criminal histories
are conducted by an NC DOC case analyst. The analyst relies on information from interviews
with the prisoner and data generated both at arrest and during prior incarcerations.
Electronic Records and Data Linking
The NC DOC provided us electronic records of data collected routinely for all inmates entering
the state prison system between January 1, 2004, and May 31, 2006. The records included
demographic and social information, conviction offense and sentence, dates of imprisonment,
mental health diagnoses, and results from education, substance abuse, and HIV-risk screenings.
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The dates and results of all tests for syphilis, HCV, and HIV conducted during the study period
were provided in a separate database by Quest Diagnostics (Atlanta, GA), a private company
contracted by the NC DOC to perform diagnostic lab work.
Electronic prison and lab data were linked by using a unique prison identification number (PIN)
assigned to all inmates upon first admission. The PIN was present in all prison records. The
3% of lab records with missing PINs were excluded from analyses. Prisoner records that were
linked to a lab record were coded to indicate that the prisoner had been tested; the remaining
prisoner records were coded as not tested.
Through a collaborative arrangement, the North Carolina Department of Health and Human
Services provided data indicating whether inmates testing positive for HIV in prison had been
previously diagnosed within the state and the original diagnosis date. Prisoners with an existing
diagnosis, as indicated by state data, were excluded from our study population to focus the
analyses on prisoners with unknown serostatus.
Before analysis, each inmate record was assigned a unique study identification number, and
all other identifying information (name, birth date, and PIN) was removed from the data. Only
records of inmates who were 18 years or older at the time of prison admission were included
for analysis.
Coding of Infectious Diseases and Mental Health Conditions
Inmates were tested for HIV with an ELISA; reactive tests were followed by Western blot.
HCV testing was conducted with antibody tests; prisoners with a Rapid Plasma Reagin titer of
1:8 or greater were coded as having “active” syphilis.17
All prisoners were assessed for TB via a Mantoux screening test at admission. Because the
Mantoux results were not electronically available, electronic medication prescription data were
used instead: prisoners prescribed anti-TB medications within 30 days of admission were coded
as having TB.
Electronic records were used to identify prisoners diagnosed with a mental health disorder
within 30 days of admission. All diagnoses were based on criteria of the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).18 Diagnoses chosen for
analysis were limited to selected DSM-IV conditions: Axis I (psychosis, bipolar disorder, major
depression, generalized anxiety disorder, dementia) and Axis II (developmental disorders and
personality disorders) mental health disorders. Prisoners diagnosed with both Axis I and Axis
II mental health disorders were coded for Axis I disorders only.
Statistical Analysis
We calculated the system-wide and prison-specific proportions of inmates tested for HIV
during their admission. For the 12% of prisoners with multiple imprisonments during the study
period, only their most recent admission was used. For all prisoners, admission was uniformly
defined as spanning the first 21 days of imprisonment. All HIV tests performed on or after
imprisonment day 22 were defined as postadmission tests. The postadmission incidence rate
of HIV testing was estimated by dividing the total number of postadmission tests by the total
number of postadmission person-days among those inmates not tested during admission. HIV
testing proportions, which were based on testing at any time during imprisonment, were
calculated for men and women separately by variable level.
Bivariate associations between testing status and inmate characteristics were estimated with
gender-specific log binomial models; multivariate associations were estimated by adding: (1)
variables with statistically significant (P<.05) bivariate associations, (2) indicator variables for
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intake facility, and (3) a dichotomous summary variable for risky behavior coded “yes” if the
prisoner had any of the following conventional HIV risk behaviors: sex with multiple partners,
sexual activity as or with a sex worker, sharing of needles, receipt of a blood transfusion during
1978 to 1985, men who have sex with other men (MSM; assessed only among men), and sex
with MSMs and sex with injection drug users (both assessed only among women).
Information on conventional HIV risk behaviors was collected in only 1 of the 2 female intake
prisons, so analysis of these behaviors among women was limited to a single facility. However,
because these variables were not associated with HIV testing, they were not used in the
covariate-adjusted model. Conventional risk behavior data were also missing for about 18%
of men. To assess the effect of the missing data, we conducted a complete case analysis, an
analysis restricted to intake facilities with minimal missing data, and an analysis based on
multiple imputation of missing data. Imputation was carried out by using Amelia II algorithms
(using version 2.5.0 of R) because of its facility with categorical variables.19,20 The multiple
imputation model included the variables evaluated in the complete case analyses plus 6
variables of modest clinical interest (e.g., ever drink excessively, ever tired). Five imputation
data sets were generated and analyzed by using PROC MIANALYZE in SAS version 9.1 (SAS
Institute, Cary, NC). All other analyses were also conducted in SAS.
RESULTS
During the study period, 54664 inmates who were 18 years or older entered the NC DOC;17
of these prisoners were excluded from our analysis because they were admitted to a prison
without a processing center. To focus our analysis on testing in prisoners with unknown
serostatus, we excluded the 631 prisoners who were tested for HIV in prison despite state health
department records indicating a preexisting HIV diagnosis.
Eighty-six percent of the inmates were male (Table 1). A greater proportion of men than women
were Black, employed before their incarceration, and recidivists. The median sentence length
was 12.2 months (25th, 75th percentiles=3.2, 24.3 months) for men and 3.2 months (25th, 75th
percentiles=2.0, 14.2 months) for women.
Intake prison populations differed by median age and percentage non-White. In the 2 female
facilities, the median ages were 33 and 35 years and the percentages non-White were 44.9%
and 47.2%. In the male facilities, the median ages in the 2 prisons for young adults were 18
and 21 years and ranged between 33 and 36 years for the other 4 intake prisons. The proportion
non-White in the male intake prisons ranged from 52.3% to 72.9%.
Thirty-four percent (n=18435) of all entrants received an HIV test during admission, but the
percentage varied from 1% to 84% across processing centers: within each female processing
center, more than 80% of entrants were tested for HIV; within 4 of the 6 male processing
centers, fewer than 15% of the entrants were tested (Figure 1).
The 35581 inmates not tested for HIV during admission were imprisoned for a total of 20197
person-years during the study period. Among these inmates, 2236 (6.3%) were tested for HIV
at a rate of 1.1 tests per 10 person-years in prison. Postadmission tests constituted 10.8% (2236
of 20671) of all HIV tests.
Among female prisoners, 85.7% were tested for HIV during admission or postadmission.
Statistically significant bivariate associations with HIV testing were observed for race,
previous time served, and sentence length. Compared with White women, “other” women (i.e.,
non-Whites and non-Blacks, including those coded as Indian, Asian or Oriental, other, or
unknown) were less likely to be tested for HIV (relative risk [RR]=0.86; 95% confidence
interval [CI]=0.80, 0.93). Also, women were less likely to be tested if they had never been
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imprisoned in the NC DOC previously (RR=0.92; 95% CI=0.90, 0.94). Compared with women
with sentences of less than 3 months, women with sentences of 3 to 6 months or 7 to 18 months
were more likely to be tested (3 to 6 months: RR=1.09; 95% CI=1.06, 1.11; 7 to 18 months:
RR=1.07; 95% CI=1.04, 1.10), but those with sentences of 19 months or greater were less
likely to be tested (RR=0.89; 95% CI=0.85, 0.93). In the 1 intake facility that assessed risk
behavior (as discussed in the Methods section), women who affirmed a history of conventional
HIV risk behaviors were no more likely to be tested than were women who denied such a
history.
Among women prisoners, the covariate-adjusted models (Table 2), which accounted for
prisoners’ intake facility, indicated that the largest discrepancy in testing was by race: women
categorized as “other” were 14% less likely to be tested for HIV than were White women
(RR=0.86; 95% CI=0.80, 0.93). There was a modest effect for intake prison (RR=0.94; 95%
CI=0.92, 0.96).
Among male prisoners, 31.7% were tested for HIV during admission or postadmission. All 22
of the covariates, except MSM, needle sharing, and syphilis, were associated with test receipt
(Table 3). Notably, men categorized as Black and “other” were, respectively, nearly 30% and
40% less likely to be tested for HIV than were Whites.
In the covariate-adjusted analysis, male prisoners with a history of heroin use, cocaine or crack
use, HIV-specific behaviors, and a medication history indicative of TB were at least 10% as
likely to be tested for HIV as were those without these attributes (Table 2). Black men were
13% less likely to be tested for HIV than were White men (RR=0.87; 95% CI=0.85, 0.90).
After adjustment for covariates, intake prison effects were still substantial. Compared with the
referent group, males at intake prison 1, the relative risks of testing among males at intake
prisons 2 through 6 were: prison 2, RR=0.33 (95% CI=0.31, 0.35); prison 3, RR=0.39 (95%
CI=0.35, 0.44); prison 4, RR=0.90 (95% CI=0.87, 0.92); prison 5, RR=0.16 (95% CI=0.13,
0.19); and prison 6, RR=0.14 (95% CI=0.12, 0.15).
Except for attenuation of the RRs for “other” race, no previous time served, and positive
syphilis results, results from the analysis restricted to intake facilities with minimal missing
data (<2%) and the analysis based on multiple imputation were nearly identical to the results
of the complete case analysis (see appendix table 4, available as a supplement to the online
version of this article at http://www.ajph.org).
DISCUSSION
Because national guidelines promote widespread access to HIV testing, it is important to assess
testing among high-risk populations including prisoners. We found that nearly 40% of
prisoners were tested for HIV and that the vast majority of tests were conducted as part of the
admission process. Although testing varied modestly by prisoner characteristics, it varied
widely across intake prison. This observation is important given that previous studies of HIV
testing have been conducted in smaller prison systems with only a single intake prison or
without regard to multiple intake prisons.9-14
Little research is available that might explain the variation in facility testing rates. One study
examining the relation between organizational structure and HIV testing in a national sample
of correctional facilities found that organization size was a predictor of testing but other
constructs were not.21 In our data, there was no apparent relation between organization size
and testing practices.
Brief interviews with key informants in the NC DOC indicated that facility differences may
reflect the priorities assigned by the chief medical professional at each prison, available
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resources, and, consequently, the manner and setting in which testing is offered. Given the
nature of our study—a retrospective analysis of laboratory data—we had little information
regarding testing practices during the study period. However, data collected in Fall 2008
suggest that at that time, the manner and setting of testing differed significantly across intake
prisons: testing was either (1) offered privately, (2) offered in a group setting after an HIV
presentation, or (3) simply available upon “sick call” request (see appendix table 2, available
online). Notably, testing among female prisoners was tightly bound with reproductive health
and in 1 prison was offered in an opt-out manner.
Testing practices in the NC DOC have been dynamic over time, making it difficult to draw
inferences between practices in 2008 and our findings from the study period, 2004 to 2006.
Nevertheless, it is reasonable to conclude from these data that testing rates are higher when
testing is easily available and offered privately. Although not well studied, prisoners’ concerns
about confidentiality and stigma likely play an important role in their willingness to be tested.
Whereas these concerns are pertinent in any setting, they may have particular resonance among
prisoners given the closed nature of their environment. More formal evaluation of these
constructs as well as structural-level factors affecting facility testing rates will soon be
underway in the NC DOC to better unify the provision of testing across intake prisons.
In nearly all state prison systems, including North Carolina’s, HIV testing is available
throughout inmates’ incarceration. However, in our study population, the proportion of
prisoners tested for HIV after the 21-day admission period was relatively small (6%). Where
testing rates are low and sentences lengthy, providing periodic opportunities for prisoners to
be tested for HIV could increase acceptance of testing, and repeat testing of prisoners testing
negative at admission could be useful in monitoring intraprison transmission.2
Of concern, non-Whites were less likely to be tested for HIV than were Whites. Women with
the racial category “other” were 14% less likely to be tested than were White women, and men
categorized as “other” or Black were 40% and 30%, respectively, less likely to be tested than
were White men.
For men, much of the difference in testing across racial category may be explained by
differences in the racial composition and testing rate of the intake prisons. The intake prison
with the greatest number of non-Whites (prison 2) tested less than 10% of all inmates. Whether
racial composition could have affected facility testing rates is unclear. Nevertheless, after
accounting for intake prison and other characteristics associated with testing, Black men and
women characterized as “other” were still less likely to be tested for HIV than were Whites.
Studies among other prisoner populations have also reported lower testing rates among
prisoners who were not White.10,12,22 Given the higher prevalence of HIV among non-Whites
than among Whites,7 greater testing of prisoners who are not White is an important step in
improving case finding. More effort is needed to understand prisoners’ possible reluctance to
be tested as well as the institutional barriers to testing.
Among men, prisoners reporting any conventional HIV risk behavior, heroin use, or crack or
cocaine use were 10% more likely to be tested for HIV than were prisoners not disclosing these
behaviors, and prisoners with TB disease were 20% more likely to be tested than were prisoners
without TB. However, prisoners with active syphilis infection were no more likely to be tested
for HIV than were those without syphilis infection, and although only a small proportion
(<10%) of prisoners were tested for HCV, we found an inverse relation between HCV
seropositivity and HIV testing. Given that syphilis, HCV, and HIV share routes of transmission,
greater testing among syphilis- and HCV-infected populations may yield a relatively high
proportion of HIV-infected individuals.
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The CDC has recommended that HIV testing be available widely and offered routinely (i.e.,
via opt-out testing) in correctional health care facilities.15,16 Routine HIV testing in prisons
could potentially have a profound impact on case identification. Routine HIV testing in the
Rhode Island DOC detected about one third of all HIV infections in the state during the 1990s.
23 In comparison, only 7% of new HIV cases in North Carolina are detected in correctional
facilities (W. Jones, North Carolina Division of Public Health, personal communication, 2007).
Increasing the availability and use of HIV testing in the NC DOC may be an efficient way to
improve case finding in the state.
In light of our study findings and recommendations from the CDC, state legislators, community
members and the NC state department of health, the NC DOC adopted a policy of routine opt-
out testing beginning in November 2008. As in other prison systems, efforts to increase testing
rates in the NC DOC should be approached with care: in the prison setting, which is designed
to limit personal liberties, there is a fine line between encouragement and coercion. In a
qualitative study of attitudes toward HIV testing among prisoners in 4 states, some inmates
reported that HIV testing in their prison was mandatory despite their residing in prisons with
a policy of voluntary testing.24 With such misperceptions (or inconsistent application of
policy), state prison systems should ensure that consent-based HIV testing is truly voluntary.
In the North Carolina prison system, we will be evaluating the testing process under this new
policy of opt-out testing to ensure that testing is widely available to inmates but is not coercive.
Our study had some limitations. First, our study relied on routinely collected administrative
data and did not include the full gamut of factors affecting testing (e.g., inmates’ perceptions
of confidentiality and HIV stigma); moreover, the phrasing of some risk assessment items was
vague. Second, validation of administrative data was not possible because of the retrospective
design of this study. Third, approximately 23% of the data specific to HIV risk behaviors were
missing. These data limited the scope of our analyses among women, but with most women
tested for HIV, these variables would likely have demonstrated little association with testing.
For the men, we assessed the effect of the missing data by comparing the results from a complete
case analysis, a restricted population with minimal missing data, and an analysis using
(multiply) imputed data; the effect estimates across analyses differed little. Fourth, data from
the state department of health allowed us to exclude from the analyses prisoners testing positive
for HIV who previously had been diagnosed in North Carolina; however, we were unable to
identify and exclude prisoners who declined testing because of a previous diagnosis. Finally,
informant interviews suggest that the systemwide testing policy was likely implemented
differently across facilities. Unfortunately, information about providers’ practices and their
interpretation of the testing policy was not available through this retrospective analysis of
laboratory data.
Prisons have been recognized as an important point of contact with populations who are at
increased risk of disease and who have little regular access to health care. To better utilize the
opportunity to improve public health through the prison system, evaluations of prison health
care services are greatly needed. In our study, we found that there were wide variations in
testing rates across intake prisons, racial disparities in testing, and few tests provided after the
admission process. The NC prison system has responded by adopting the CDC’s
recommendation for opt-out testing and by working in partnership with university-based
researchers to further evaluate the testing process. To fully realize the public health gains made
by increased testing in the prison system, it is also essential that agencies outside the NC DOC,
such as the state health department, help to provide adequate resources to prisoners after their
release. Other state prison systems with consent-based testing could benefit from similar
partnerships as the role of prisons expands in HIV case detection.
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Proportion of newly admitted inmates tested for HIV within the 2 female and 6 male intake
facilities of the North Carolina state prison system, January 2004 to May 2006.
Note. Total intake population in parentheses.
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TABLE 1
Characteristics of Adult Prisoners Entering the North Carolina State Prison System: January 2004–May 2006
Women, No. or % Men, No. or %












 High school degree or GED 46.2 47.0







Previous time served, mo
 None 60.5 44.0







 < 3 31.3 20.4
Drug-related conviction ever 40.4 37.5
Sex-related conviction ever 1.3 6.2
Cocaine or crack use ever 63.0 32.7
Heroin use ever 5.8 1.9
MSMc … 0.7
Multiple sexual partnersc 26.4 21.2
Prostitutionc 16.1 5.9
Share needlesc 9.0 3.0
Blood transfusionc 2.8 0.7
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Women, No. or % Men, No. or %
Total 6804 47 212
Sex with needle sharerd 15.6 …
Sex with MSMd 2.9 …
Mental healthe
 Axis I 6.5 2.3












Note. MSM = men who have sex with men.
a
Data missing for ≤20 observations per gender.
b
Data missing for 471 (6.9%) women and 2376 (5.0%) men.
c
Data not collected from 3976 (58%) women and 8333 (18%) men.
d
Data not collected from 3976 (58%) women and all men.
e
Axis I: psychosis, bipolar disorder, major depression, generalized anxiety disorder, and dementia. Axis II: personality disorder, developmental disability.
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TABLE 2
Covariate-Adjusted Associations Between HIV Test Receipt and Characteristics of Adult Male and Female North
Carolina State Prisoners: January 2004–May 2006
Women, RR (95% CI) Men, RR (95% CI)
Age group, y
 ≥45 0.98 (0.95, 1.02) 0.95 (0.91, 0.99)
 35–44 0.99 (0.96, 1.01) 0.98 (0.94, 1.02)
 25–34 1.00 (0.97, 1.02) 0.95 (0.91, 0.99)
 18–24 (Ref) 1.00 1.00
Race
 Black 0.98 (0.96, 1.00) 0.87 (0.85, 0.90)
 Other 0.86 (0.80, 0.93) 0.99 (0.93, 1.05)
 White (Ref) 1.00 1.00
Education
 College 0.98 (0.95, 1.01) 1.04 (0.99, 1.09)
 High school graduate or GED 0.99 (0.97, 1.01) 1.05 (1.03, 1.08)
 Less than high school (Ref) 1.00 1.00
Employment
 Unemployed 1.02 (1.00, 1.04) 0.97 (0.94, 0.99)
 Employed (Ref) 1.00 1.00
Marital status
 Not married or separated 1.03 (1.00, 1.05) 1.02 (0.99, 1.05)
 Married (Ref) 1.00 1.00
IQ test result
 ≤80 1.01 (0.98, 1.05) 0.93 (0.90, 0.97)
 81–100 1.03 (1.01, 1.05) 0.97 (0.95, 1.00)
 ≥101 (Ref) 1.00 1.00
Previous time served, mo
 None … 1.06 (1.03, 1.09)
 > 0–6 … 1.04 (1.01, 1.08)
 7–12 … 1.02 (0.99, 1.06)
 ≥13 (Ref) … 1.00
Drug-related conviction evera 1.03 (1.01, 1.05) 0.98 (0.96, 1.00)
Sex-related conviction evera 0.90 (0.81, 1.02) 0.97 (0.92, 1.03)
Heroin use evera 1.02 (0.98, 1.05) 1.12 (1.05, 1.19)
Cocaine or crack use evera 1.06 (1.03, 1.08) 1.10 (1.08, 1.13)
Conventional HIV risk behaviorb … 1.10 (1.07, 1.13)
Mental healthc
 Axis I 0.98 (0.94, 1.02) 0.99 (0.93, 1.06)
 Axis II 1.00 (0.97, 1.04) 1.05 (0.99, 1.12)
 Neither (Ref) 1.00 1.00
Syphilis
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Women, RR (95% CI) Men, RR (95% CI)
 Positive … 1.00 (0.95, 1.05)
 Negative (Ref) … 1.00
Tuberculosis
 Positive 0.99 (0.90, 1.10) 1.21 (1.16, 1.26)
 Negative (Ref) 1.00 1.00




Included MSM (men only), multiple sexual partners, prostitution, needle sharing, sex with MSM (women only), sex with injection drug user (women
only), blood transfusion 1978–1985.
c
Axis I: psychosis, bipolar disorder, major depression, generalized anxiety disorder, and dementia. Axis II: personality disorder, developmental disability.
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TABLE 3
Associations Between HIV Test Receipt and Characteristics of Adult Male North Carolina State Prisoners: January
2004–May 2006
No. HIV Tested, % (No.) RR (95% CI)
Age group, y
 ≥45 6 604 36.6 (2 415) 1.94 (1.84, 2.03)
 35–44 12 243 38.3 (4 690) 2.03 (1.94, 2.12)
 25–34 16 136 34.4 (5 557) 1.82 (1.75, 1.90)
 18–24 (Ref) 12 229 18.9 (2 309) 1.00
Race
 Black 26 221 27.7 (7 272) 0.71 (0.70, 0.73)
 Other 2 992 23.6 (707) 0.61 (0.57, 0.65)
 White (Ref) 17 999 38.9 (6 992) 1.00
Education
 College 3 464 35.7 (1 237) 1.24 (1.18, 1.30)
 High school graduate or GED 22 209 33.8 (7 524) 1.18 (1.14, 1.21)
 Less than high school (Ref) 21 539 28.8 (6 210) 1.00
Employment
 Unemployed 17 006 26.9 (4 581) 0.78 (0.76, 0.81)
 Employed (Ref) 30 187 34.4 (10 385) 1.00
Marital status
 Not married or separated 40 295 31.4 (12 644) 0.93 (0.90, 0.97)
 Married (Ref) 6 897 33.7 (2 325) 1.00
IQ test result
 ≤80 11 893 26.4 (3 141) 0.69 (0.66, 0.71)
 81–100 26 098 31.7 (8 280) 0.82 (0.80, 0.85)
 ≥101 (Ref) 9 221 38.5 (3 550) 1.00
Previous time served, mo
 None 20 793 27.0 (5 604) 0.74 (0.72, 0.77)
 > 0–6 6 540 34.7 (2 269) 0.96 (0.92, 1.00)
 7–12 4 777 34.2 (1 634) 0.95 (0.90, 0.99)
 ≥13 (Ref) 15 102 36.2 (5 464) 1.00
Sentence length,a mo
 ≥19 13 860 30.0 (4 161) 0.79 (0.76, 0.82)
 7–18 11 610 31.1 (3 615) 0.82 (0.79, 0.85)
 3–6 10 214 28.8 (2 938) 0.75 (0.72, 0.78)
 < 3 (Ref) 9 152 38.2 (3 496) 1.00
Drug-related conviction ever
 Yes 17 698 30.0 (5 314) 0.92 (0.89, 0.94)
 No (Ref) 29 514 32.7 (9 657) 1.00
Sex-related conviction ever
 Yes 2 902 28.2 (819) 0.88 (0.83, 0.94)
 No (Ref) 44 310 31.9 (14 152) 1.00
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No. HIV Tested, % (No.) RR (95% CI)
Cocaine or crack use ever
 Yes 15 425 36.7 (5 667) 1.26 (1.22, 1.29)
 No (Ref) 31 787 29.3 (9 304) 1.00
Heroin use ever
 Yes 872 39.7 (346) 1.26 (1.16, 1.37)
 No (Ref) 46 340 31.6 (14 625) 1.00
MSM
 Yes 268 38.8 (104) 1.10 (0.95, 1.28)
 No (Ref) 38 611 35.3 (13 622) 1.00
Multiple sexual partnersb
 Yes 8 224 29.3 (2 410) 0.79 (0.77, 0.82)
 No (Ref) 30 655 36.9 (11 316) 1.00
Prostitutionb
 Yes 2 276 37.9 (863) 1.08 (1.02, 1.14)
 No (Ref) 36 603 35.1 (12 863) 1.00
Shared needlesb
 Yes 1 163 34.9 (406) 0.99 (0.91, 1.07)
 No (Ref) 37 716 35.3 (13 320) 1.00
Blood transfusionb
 Yes 277 45.1 (125) 1.28 (1.12, 1.46)
 No (Ref) 38 602 35.2 (13 601) 1.00
Mental healthc
 Axis I 1 107 40.1 (444) 1.28 (1.19, 1.37)
 Axis II 1 263 34.3 (433) 1.09 (1.01, 1.18)
 Neither (Ref) 44 842 31.4 (14 094) 1.00
HCV
 Positive 1485 55.4 (822) 0.89 (0.82, 0.97)
 Negative (Ref) 531 62.0 (329) 1.00
 No test 45 196 30.6 (13 820)
Syphilis
 Positive 1 956 39.8 (778) 1.01 (0.95, 1.07)
 Negative (Ref) 33 962 39.4 (13 380) 1.00
 No test 11 294 7.2 (813)
Tuberculosis
 Positive 1797 35.5 (637) 1.12 (1.05, 1.20)
 Negative (Ref) 45 415 31.63 (1 434) 1.00
Note. MSM = men who have sex with men; RR = relative risk.
a
Prisoners with missing data who were tested for HIV = 32.0% (761 of 2376).
b
Prisoners with missing data who were tested for HIV = 14.9% (1245 of 8333).
c
Axis I: psychosis, bipolar disorder, major depression, generalized anxiety disorder, and dementia. Axis II: personality disorder, developmental disability.
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